Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery

• Status: Not yet recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of I/V nalbuphine versus I/V xylocain in attanuation of pressor response during intubation and laryngeoscopy in patients undergoing for thyroid surgery,selection of better supressor agent minimises the drug repated side effects like hypertention tachycardia but also helps in heamodynamically stability at induction.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sheikh Zayed Medical College
• Treatments: Lidocaine; Nalbuphine

Criteria

Inclusion Criteria:

• middle age(18_40)

• Asa 1 and 2

• Non hypertensive

• Thyroid patients

• patient who gives consent

Exclusion Criteria:

• hypertensive

• Asa 3 and 4

• Patient refusal